Jim Fong
Corporate Officer/Principal bij CTI BIOPHARMA CORP.
Actieve functies van Jim Fong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CTI BIOPHARMA CORP. | Corporate Officer/Principal | 01-01-2008 | - |
Operationeel Directeur | 01-01-2017 | - |
Loopbaan van Jim Fong
Eerdere bekende functies van Jim Fong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Verkoop & Marketing | - | - |
Opleiding van Jim Fong
University of California, Los Angeles | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |